Thus, in the immunologically cold LLC1-HER2 tumor, the checkpoint molecules were expressed at low levels, and the tumor was intrinsically resistant to checkpoint blockade; R-337 resulted in sensitization to checkpoint inhibition [25]. Here, ERBB2 is linked to neoplasm.